Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Hosp Infect ; 116: 16-20, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1271690

ABSTRACT

Besides conventional prevention measures, no-touch technologies based on gaseous systems have been introduced in hospital hygiene for room disinfection. The whole-room disinfectant device Sterisafe Pro, which creates ozone as a biocidal agent, was tested for its virucidal efficacy based on Association Française de Normalisation Standard NF T 72-281:2014. All test virus titres were reduced after 150 and 300 min of decontamination, with mean reduction factors ranging from 2.63 (murine norovirus) to 3.94 (simian virus 40). These results will help to establish realistic conditions for virus inactivation, and assessment of the efficacy of ozone technology against non-enveloped and enveloped viruses.


Subject(s)
Disinfectants , Ozone , Animals , Disinfectants/pharmacology , Disinfection , Humans , Hygiene , Mice , Ozone/pharmacology , Virus Inactivation
2.
J Hosp Infect ; 120: 9-13, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1500052

ABSTRACT

The highest viral loads of severe acute respiratory syndrome coronavirus-2 are detectable in the oral cavity, so a potential reduction of infectious virus by nasal and oral sprays could reduce transmission. Therefore, the inactivation capacity of nine nasal and oral sprays was evaluated according to EN 14476. One nasal spray based on sodium hypochlorite and one oral spray containing essential oils reduced viral titres by two to three orders of magnitude. Although clinical data are still sparse, nasal and oral sprays display a more convenient application for elderly people or those who are unable to rinse/gargle.


Subject(s)
COVID-19 , Nasal Sprays , Aged , Humans , Mouth , Mouthwashes , SARS-CoV-2
3.
Antimicrobial Resistance and Infection Control ; 10(SUPPL 1), 2021.
Article in English | EMBASE | ID: covidwho-1448377

ABSTRACT

Introduction: The ongoing SARS-CoV-2 pandemic creates a significant threat to global health. Recent studies suggested the significance of throat and salivary glands as major sites of virus replication and transmission during early COVID-19 thus advocating application of oral antiseptics. Objectives: Here, we evaluated the virucidal activity of different available oral rinses, nasal sprays as well as individual compounds found in oral rinses against SARS-CoV-2. These experiments were performed under conditions mimicking nasopharyngeal secretions and investigated their respective virucidal modes of action. Methods: According to European guidelines, virucidal activity was determined with a quantitative suspension test with 30 s exposure time on VeroE6 cells. Mechanistic analysis to reveal the mode of action of antiseptic agents included density gradient centrifugation and a capsid protection assay. Results: Three of the eight oral rinses as well as two nasal sprays significantly reduced viral infectivity to up to three orders of magnitude to background levels. Mechanistic analysis revealed that treatment with benzalconiumchloride and other antiseptic agents used in mouth rinses primarily disrupted the viral envelope, without affecting viral RNA integrity. Conclusion: In summary, we provide evidence that SARS-CoV-2 can be efficiently inactivated by commercially available oral rinses and nasal sprays with respect to their compound composition, within short exposure times, thus possibly lowering the transmission of SARS-CoV-2.

5.
J Hosp Infect ; 112: 27-30, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1261926

ABSTRACT

In the ongoing SARS CoV-2 pandemic, effective disinfection measures are needed, and guidance based on the methodological framework of the European Committee for Standardization (CEN) may enable the choice of effective disinfectants on an immediate basis. This study aimed to elucidate whether disinfectants claiming 'virucidal activity against enveloped viruses' as specified in the European Standard EN 14476 as well as in the German Association for the Control of Viral Diseases/Robert Koch Institute (DVV/RKI) guideline are effectively inactivating SARS-CoV-2. Two commercially available formulations for surface disinfection and one formulation for hand disinfection were studied regarding their virucidal activity. Based on the data of this study the enveloped SARS-CoV-2 is at least equally susceptible compared to the standard test virus vaccinia used in the EN 14476 and DVV/RKI guidelines. Thus, chemical disinfectants claiming 'virucidal activity against enveloped viruses' based on the EN 14476 and DVV/RKI guidelines will be an effective choice to target enveloped SARS-CoV-2 as a preventive measure.


Subject(s)
Antiviral Agents/pharmacology , Disinfectants/pharmacology , Disinfection/standards , Hand Disinfection/standards , SARS-CoV-2/drug effects , Antiviral Agents/chemistry , COVID-19/prevention & control , Disinfectants/chemistry , Disinfection/classification , Hand Disinfection/methods , Humans , Virus Diseases/prevention & control
6.
Journal of Hospital Infection ; 111:180-183, 2021.
Article in English | MEDLINE | ID: covidwho-1208668

ABSTRACT

The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (>=4 log<sub>10</sub>) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols.

7.
J Hosp Infect ; 104(3): 246-251, 2020 Mar.
Article in English | MEDLINE | ID: covidwho-3162

ABSTRACT

Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.


Subject(s)
Betacoronavirus/drug effects , Betacoronavirus/growth & development , Coronavirus Infections/transmission , Disinfectants/pharmacology , Microbial Viability , Pneumonia, Viral/transmission , COVID-19 , Environmental Microbiology , Humans , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL